Novartis Scemblix® shows superior major molecular response
MEDIA & INVESTOR RELEASE Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard-of-care TKIs in Phase III trial for...
Stay updated with breaking news from Treatment Optimization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MEDIA & INVESTOR RELEASE Novartis Scemblix® shows superior major molecular response (MMR) rates vs. standard-of-care TKIs in Phase III trial for...
Experts discuss the critical role of specialty pharmacists in advocating for patients during challenging moments in their hemophilia treatment journey and explore precision dosing considerations and the importance of adherence to dosing guidelines.
Heather McArthur, MD, and Debu Tripathy, MD, lead a discussion on risk stratification and optimizing treatment for HER2+ early breast cancer (eBC), followed by a review of standard-of-care systemic therapy regimens in the preoperative/neoadjuvant setting.
AI and machine learning algorithms will revolutionize healthcare, improving diagnostics, personalized medicine, and drug discovery.
Society for Science proudly announces the top 300 scholars in the Regeneron Science Talent Search 2021, the nation’s oldest and most prestigious science and math competition for high school seniors.